---
layout: default
title: Propantheline
description: "Propantheline çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚ä¸­ç­‰è­‰æ“šç­‰ç´š L3ï¼ŒåŒ…å« 2 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: ä¸­è­‰æ“šç­‰ç´š (L3-L4)
nav_order: 142
evidence_level: L4
indication_count: 2
---

# Propantheline

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L3</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>2</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Propanthelineï¼šå¾æ¶ˆåŒ–æ€§æ½°ç˜åˆ°èƒƒåäºŒæŒ‡è…¸ç‚

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Propantheline å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Propantheline æ˜¯ä¸€ç¨®å‰¯äº¤æ„Ÿç¥ç¶“é˜»æ–·åŠ‘ï¼ŒåŸæœ¬ç”¨æ–¼èƒƒæ½°ç˜ã€åäºŒæŒ‡è…¸æ½°ç˜å’Œèƒƒç‚çš„æ²»ç™‚ã€‚TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**èƒƒåäºŒæŒ‡è…¸ç‚ (Gastroduodenitis)** æœ‰æ•ˆï¼Œç›®å‰æœ‰ **5 ç¯‡æ–‡ç»**æ”¯æŒé€™å€‹æ–¹å‘ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | èƒƒæ½°ç˜ã€åäºŒæŒ‡è…¸æ½°ç˜ã€èƒƒç‚ã€èƒƒé…¸éå¤š |
| é æ¸¬æ–°é©æ‡‰ç—‡ | gastroduodenitisã€peptic ulcer disease |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.90% |
| è­‰æ“šç­‰ç´š | L3 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ï¼ˆéƒ¨åˆ†è¨±å¯è­‰å·²è¨»éŠ·ï¼‰ |
| è¨±å¯è­‰æ•¸ | å¤šå¼µ |
| å»ºè­°æ±ºç­– | Go |



## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. gastroduodenitis</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.90%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Propantheline æ˜¯ä¸€ç¨®æŠ—è†½é¹¼è—¥ç‰©ï¼Œèƒ½å¤ é˜»æ–·å‰¯äº¤æ„Ÿç¥ç¶“çš„ä½œç”¨ï¼Œæ¸›å°‘èƒƒé…¸åˆ†æ³Œä¸¦é™ä½èƒƒè…¸é“çš„è •å‹•å’Œç—™æ”£ã€‚é€™äº›ä½œç”¨æ©Ÿè½‰ä½¿å…¶æˆç‚ºæ²»ç™‚æ¶ˆåŒ–æ€§æ½°ç˜å’Œèƒƒç‚çš„æœ‰æ•ˆè—¥ç‰©ã€‚</p>

<p>èƒƒåäºŒæŒ‡è…¸ç‚æ˜¯æŒ‡èƒƒå’ŒåäºŒæŒ‡è…¸åŒæ™‚ç™¼ç”Ÿçš„ç‚ç—‡ï¼Œå…¶ç—…ç†æ©Ÿè½‰èˆ‡èƒƒæ½°ç˜å’ŒåäºŒæŒ‡è…¸æ½°ç˜é«˜åº¦ç›¸é—œã€‚Propantheline é€éä»¥ä¸‹æ©Ÿè½‰å¯èƒ½æœ‰åŠ©æ–¼æ²»ç™‚èƒƒåäºŒæŒ‡è…¸ç‚ï¼š</p>

<ol>
<li>æŠ‘åˆ¶èƒƒé…¸åˆ†æ³Œï¼Œæ¸›å°‘é…¸æ€§ç’°å¢ƒå°é»è†œçš„åˆºæ¿€</li>
<li>æ¸›å°‘èƒƒè…¸é“è •å‹•ï¼Œé™ä½æ©Ÿæ¢°æ€§æå‚·</li>
<li>ç·©è§£èƒƒè…¸ç—™æ”£ï¼Œæ¸›è¼•ç–¼ç—›ç—‡ç‹€</li>

</ol>
<p>ç”±æ–¼åŸé©æ‡‰ç—‡å’Œæ–°é æ¸¬é©æ‡‰ç—‡åœ¨è§£å‰–ä½ç½®å’Œç—…ç†æ©Ÿè½‰ä¸Šé«˜åº¦ç›¸ä¼¼ï¼Œé€™å€‹é æ¸¬å…·æœ‰å¾ˆå¼·çš„åˆç†æ€§ã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡ç›¸é—œè‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

<h3>ç›¸é—œæ–‡ç»</h3>

<table>
<thead>
<tr>
<th>PMID</th>
<th>å¹´ä»½</th>
<th>é¡å‹</th>
<th>æœŸåˆŠ</th>
<th>ä¸»è¦ç™¼ç¾</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/6342335/">6342335</a></td>
<td>1983</td>
<td>RCT</td>
<td>Acta Med Scand</td>
<td>Cimetidine ä½µç”¨ä½åŠ‘é‡ propantheline æ²»ç™‚èƒƒåäºŒæŒ‡è…¸æ½°ç˜</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/761954/">761954</a></td>
<td>1979</td>
<td>Journal Article</td>
<td>Int J Clin Pharmacol</td>
<td>Trithiozine èˆ‡ propantheline åœ¨èƒƒåˆ†æ³ŒæŠ‘åˆ¶ä½œç”¨çš„æ¯”è¼ƒ</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/4798570/">4798570</a></td>
<td>1973</td>
<td>Journal Article</td>
<td>Minerva Med</td>
<td>èƒƒåäºŒæŒ‡è…¸æ½°ç˜çš„ä¿å®ˆæ²»ç™‚</td>
</tr>
<tr>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/13392433/">13392433</a></td>
<td>1956</td>
<td>Journal Article</td>
<td>Vie Med</td>
<td>Propantheline ç”¨æ–¼èƒƒåäºŒæŒ‡è…¸æ½°ç˜çš„æŠ—è†½é¹¼æ²»ç™‚</td>
</tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. irritable bowel syndrome</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.16%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ5 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3338825/" target="_blank">3338825</a></td><td>1988</td><td>Article</td><td>Indian journal of ga</td><td>Colonic myoelectrical activity in irritable bowel syndrome b...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2697886/" target="_blank">2697886</a></td><td>1989</td><td>Article</td><td>The Quarterly journa</td><td>Long-term treatment of irritable bowel syndrome: results of ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2888056/" target="_blank">2888056</a></td><td>1987</td><td>Article</td><td>Minerva dietologica </td><td>[Multicenter study on the effectiveness and tolerance of a b...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/353089/" target="_blank">353089</a></td><td>1978</td><td>Article</td><td>Journal of clinical </td><td>Controlled clinical trial of sedative-anticholinergic drugs ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11488427/" target="_blank">11488427</a></td><td>2001</td><td>Article</td><td>Japanese journal of </td><td>Effects of YM905, a novel muscarinic M3-receptor antagonist,...</td></tr>
</tbody>
</table>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| å…§è¡›è—¥è¼¸å­—ç¬¬002640è™Ÿ | ç›Šèƒƒå¯§ | éŒ åŠ‘ | èƒƒã€åäºŒæŒ‡è…¸æ½°ç˜ã€èƒƒç‚ã€å­å®®ç—™æ”£ï¼ˆå·²è¨»éŠ·ï¼‰ |
| å…§è¡›è—¥è£½å­—ç¬¬001973è™Ÿ | èƒƒç™¾åº·ç‰‡ | éŒ åŠ‘ | æ€¥æ…¢æ€§èƒƒç‚ã€èƒƒé…¸éå¤šã€èƒƒç—›ã€èƒƒåŠåäºŒæŒ‡è…¸æ½°ç˜ï¼ˆå·²è¨»éŠ·ï¼‰ |

## å®‰å…¨æ€§è€ƒé‡

å®‰å…¨æ€§è³‡è¨Šè«‹åƒè€ƒåŸå» ä»¿å–®ã€‚

æŠ—è†½é¹¼è—¥ç‰©çš„å¸¸è¦‹æ³¨æ„äº‹é …ï¼š
- å£ä¹¾
- è¦–åŠ›æ¨¡ç³Š
- å°¿æ»¯ç•™ï¼ˆç‰¹åˆ¥æ˜¯æ”è­·è…ºè‚¥å¤§æ‚£è€…ï¼‰
- ä¾¿ç§˜


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é«˜è¡€å£“** ğŸ”´ Major
- æ³¨æ„äº‹é …ï¼šCardiovascular effects of anticholinergics may exacerbate hypertension...

**Fever** ğŸ”´ Major
- æ³¨æ„äº‹é …ï¼šAtropine-like agents may increase the risk of hyperthermia in patients with fever by producing anhidrosis...

**Psychotic Disorders** ğŸŸ¡ Moderate
- å¯èƒ½éœ€è¦èª¿æ•´åŠ‘é‡ã€‚

**Arrhythmias, Cardiac** ğŸŸ¢ Minor
- æ³¨æ„äº‹é …ï¼šPatients with tachycardia should be supervised closely during treatment with anticholinergic agents...

**Diabetic Neuropathies** ğŸŸ¢ Minor
- æ³¨æ„äº‹é …ï¼šAgents with anticholinergic activity can exacerbate many of the manifestations of autonomic neuropathy, including tachycardia, anhidrosis, bladder ato...

**Intestinal Obstruction** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

**é’å…‰çœ¼** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**Urinary Bladder Neck Obstruction** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**Tardive Dyskinesia** ğŸŸ¢ Minor
- æ‡‰é¿å…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**Dysentery** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é…’ç²¾** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šç”¢ç”Ÿå”åŒä½œç”¨ã€‚å¯èƒ½å¢å¼·è—¥æ•ˆã€‚
- å»ºè­°ï¼šå»ºè­°é¿å…ä½µç”¨ã€‚


## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šGo**

**ç†ç”±ï¼š**
èƒƒåäºŒæŒ‡è…¸ç‚èˆ‡ propantheline çš„åŸé©æ‡‰ç—‡ï¼ˆèƒƒæ½°ç˜ã€åäºŒæŒ‡è…¸æ½°ç˜ã€èƒƒç‚ï¼‰åœ¨ç—…ç†æ©Ÿè½‰ä¸Šé«˜åº¦ç›¸é—œã€‚Propantheline çš„æŠ—è†½é¹¼ä½œç”¨ï¼ˆæŠ‘åˆ¶èƒƒé…¸åˆ†æ³Œã€æ¸›å°‘èƒƒè…¸è •å‹•ï¼‰å°æ–¼èƒƒåäºŒæŒ‡è…¸ç‚çš„æ²»ç™‚å…·æœ‰æ˜ç¢ºçš„è—¥ç†å­¸åŸºç¤ã€‚æ–‡ç»ä¸­å·²æœ‰ propantheline ç”¨æ–¼èƒƒåäºŒæŒ‡è…¸æ½°ç˜æ²»ç™‚çš„è‡¨åºŠç ”ç©¶ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- ç¢ºèªå°ç£ç›®å‰æ˜¯å¦æœ‰æœ‰æ•ˆçš„è¨±å¯è­‰ï¼ˆéƒ¨åˆ†å·²è¨»éŠ·ï¼‰
- è©•ä¼°èˆ‡ç¾ä»£è³ªå­æ³µæŠ‘åˆ¶åŠ‘ï¼ˆPPIï¼‰ç›¸æ¯”çš„å®šä½
- åˆ¶å®šé©ç•¶çš„åŠ‘é‡æ–¹æ¡ˆ

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Inositol]({{ "/drugs/inositol/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Interferon Beta-1B]({{ "/drugs/interferon_beta-1b/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Durvalumab]({{ "/drugs/durvalumab/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Vinorelbine]({{ "/drugs/vinorelbine/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Dorzolamide]({{ "/drugs/dorzolamide/" | relative_url }}) - è­‰æ“šç­‰ç´š L3

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Propanthelineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/propantheline/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_propantheline,
  title = {Propanthelineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/propantheline/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
